Since a broad phenotypic variability, mainly due to large tumor spectrum and age of onset, has been usually observed in individuals affected by LS and their family members harboring the same germline LPV/PV in MMR genes (25), the choice of the most suitable criteria and optimal screening strategy for selecting subjects to undergo to germline genetic testing are still today debated. This evidence concerns the gene MRC1 and Leigh syndrome.